The price of nucleic acid testing at public medical institutions in Beijing has been reduced from 180 yuan to 120 yuan.

Medical Network June 29th afternoon, Beijing's new coronary virus pneumonia epidemic prevention and control work 135th press conference, Beijing Municipal Medical Security Bureau Deputy Director, press spokesman Du Xin introduced, from the beginning of the outbreak, the Municipal Medical Security Bureau, in accordance with national requirements, suspected and confirmed new coronary pneumonia patients testing and treatment of related drugs, medical services and other temporary medical insurance into the scope of reimbursement, after reimbursement of personal burden by the financial funds to ensure that the cost of treatmentWith the development and change of the situation of epidemic prevention and control, from May 19, the Municipal Health Insurance Bureau, The Municipal Finance Bureau and other relevant departments to further the state and the city's provisions of the "should be inspected" people into the scope of protection, the insured personnel in the medical insurance fixed-point medical institutions for nucleic acid testing, according to the provisions of reimbursement, the personal burden of the two levels of financial burden by the urban area.Recently, in order to further reduce the cost of nucleic acid detection and the burden of public expenses, combined with the price changes of testing reagents, the Municipal Health Insurance Bureau will adjust the price of nucleic acid testing projects synchronously with the departments of health, finance and other departments, from June 25 onwards, the city's public medical institutions nucleic acid testing price from 180 yuan per time reduced to 120 yuan, the price is the highest government guidance price, medical institutions may not float, but according to their own circumstances, floating range is not limitedNon-public medical insurance fixed-point medical institutions in the provision of nucleic acid testing services for insured personnel also in accordance with the above-mentioned policyNon-public non-medical insurance fixed-point medical institutions (such as third-party testing institutions, non-medical insurance fixed-point privatehospitals, etc.) in accordance with the relevant provisions of the State and the city, the implementation of market adjustment price management, testing prices by the institutions independently set.